MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Alleviation of Parkinson’s and Associated Depression using Silymarin in Rotenone induced Mice Model of Parkinson’s Disease

    D. Khatri (Pune, India)

    Objective: The present study was undertaken in order find out the possible neuroprotective and antidepressant potential of Silymarin. The neuroprotective and antidepressant potential was evaluated…
  • 2019 International Congress

    The role of dysfunctional attentional processing in isolated minor hallucinations in Parkinson’s disease

    H. Bejr-Kasem, J. Pagonabarraga, S. Martínez-Horta, F. Ruiz-Martínez, F. Bernasconi, F. Sampedro, J. Marín-Lahoz, A. Horta-Barba, I. Aracil-Bolaños, B. Pascual-Sedano, O. Blanke, J. Kulisevsky (Barcelona, Spain)

    Objective: To explore attentional processing deficits in Parkinson's disease (PD) with minor hallucinations using a selective visual attention task. Background: Recent literature points to a…
  • 2019 International Congress

    Psychosis in Prodromal Parkinson’s disease

    I. Pachi, M. Maraki, M. Kosmidis, M. Yannakoulia, E. Dardiotis, G. Hadjigeorgiou, P. Sakka, G. Xiromerisiou, M. Stamelou, N. Scarmeas, L. Stefanis (Athens, Greece)

    Objective: To investigate a possible association between psychosis and prodromal Parkinson’s disease (PD) in a population-based cohort, the Hellenic Longitudinal Investigation of Aging and Diet…
  • 2019 International Congress

    Opinions and clinical practices related to diagnosing and managing patients with functional (psychogenic) movement disorders: from 2009 to 2019

    K. Lafaver, D. Bega, M. Hallett, A. Lang, S. Lidstone, C. Maurer, F. Morgante, D. Perez, C. Stephen, J. Stone, T. Teodoro, A. Wu, A. Dwivedi, A. Espay (Louisville, KY, USA)

    Objective: (1) To examine current opinion and clinical practices related to diagnosis and management of Functional Movement Disorders (FMD); and (2) to determine if practice…
  • 2019 International Congress

    MYORG is associated with recessive primary familial brain calcification

    D. Arkadir, A. Lossos, D. Rahat, M. Abu Snineh, V. Meiner (Jerusalem, Israel)

    Objective: To investigate the genetic basis of the recessive form of primary familial brain calcification (PFBG) and study pathways linking a novel gene with known…
  • 2019 International Congress

    Comparison of Gene Expression in Parkinson’s Disease and Bipolar Disorder

    FV. Delos Reyes (Quezon City, Philippines)

    Objective: The aim of this research is to compare the overexpressed genes in patients with Parkinson's Disease (PD) and patients with Bipolar Disorder (BD) versus…
  • 2019 International Congress

    Genetic panel testing in Parkinson’s disease

    T. Toomsoo, I. Rubanovich, I. Kalju, S. Ott, A. Lindmäe, M. Mällo, K. Jaakson, K. Joost, K. Vender (Tallinn, Estonia)

    Objective: To evaluate effectiveness of panel testing of known Parkinson's disease (PD) related genes in clinical practice. Background: It is widely recognised that monogenic forms…
  • 2019 International Congress

    Hereditary and geneological aspects of Parkinson’s disease and essential tremor in people of Uzbek nationality

    R. Matmurodov, K. Khalimova (Tashkent, Uzbekistan)

    Objective: To study the genealogic features of Parkinson’s disease and essential tremor in people of Uzbek nationality. Background: Parkinson's disease (PD)  and essential tremor (ET)…
  • 2019 International Congress

    A coding VPS13C haplotype is associated with reduced risk for Parkinson disease

    U. Rudakou, J. Ruskey, L. Krohn, S. Laurent, D. Spiegelman, L. Greenbaum, G. Yahalom, A. Desautels, J. Montplaisir, S. Fahn, C. Waters, L. Levy, C. Kehoe, S. Narayan, Y. Dauvilliers, N. Dupré, S. Hassin-Baer, R. Alcalay, G. Rouleau, E. Fon, Z. Gan-Or (Montreal, QC, Canada)

    Objective: To study the role of coding VPS13C variants in a large cohort of late-onset PD (LOPD) patients. Background: VPS13C is within a risk locus…
  • 2019 International Congress

    High rate of mutations in complex dystonia revealed by exome sequencing

    T. Wirth, C. Tranchant, N. Drouot, B. Keren, L. Cif, C. Mignot, R. Lefaucheur, L. Lion-François, A. Méneret, D. Gras, E. Flamand-Roze, C. Laroche, P. Burbaud, S. Bannier, O. Boukbiza, MA. Spitz, V. Laugel, M. Bereau, D. Doummar, G. Rudolf, M. Anheim, J. Chelly (Illkirch-Graffenstaden, France)

    Objective: This study aimed at identifying the missing genetic causes in dystonia without diagnosis following movement disorders gene panel sequencing. Background: Dystonia aetiologies are highly…
  • « Previous Page
  • 1
  • …
  • 69
  • 70
  • 71
  • 72
  • 73
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley